| Terra Innovatum Provides Update on Annual Report Filing Process |
Globe Newswire |
04/17 |
18:26 |
| Flixy Smart TV Stick Claims Evaluated: The Most Recommended TV Streaming Stick Device Without Costly Subscriptions |
Globe Newswire |
04/17 |
17:46 |
| Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025 |
Globe Newswire |
04/17 |
17:30 |
| CVB Financial Corp. Announces Completion of Merger with Heritage Commerce Corp |
Globe Newswire |
04/17 |
17:20 |
| Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency |
Globe Newswire |
04/17 |
17:20 |
| ZSPC Investor News: If You Have Suffered Losses in zSpace Inc. (NASDAQ: ZSPC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
04/17 |
17:19 |
| Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) |
Globe Newswire |
04/17 |
17:15 |
| Sow Good Inc. Announces Reverse Stock Split |
Globe Newswire |
04/17 |
17:07 |
| Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting |
Globe Newswire |
04/17 |
16:49 |
| Sysco Declares Increase to Quarterly Dividend Payment |
Globe Newswire |
04/17 |
16:35 |
| Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Globe Newswire |
04/17 |
16:15 |
| TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call |
Globe Newswire |
04/17 |
16:10 |
| Vera Bradley Terminates Existing Shareholder Rights Plan |
Globe Newswire |
04/17 |
16:05 |
| ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting |
Globe Newswire |
04/17 |
16:05 |
| Talen Energy Announces Pricing of Senior Notes |
Globe Newswire |
04/17 |
16:05 |
| SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders |
Globe Newswire |
04/17 |
16:05 |
| Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 |
Globe Newswire |
04/17 |
16:05 |
| QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option |
Globe Newswire |
04/17 |
16:05 |
| VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE |
Globe Newswire |
04/17 |
16:03 |
| Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares |
Globe Newswire |
04/17 |
16:02 |
| Hingham Savings Reports First Quarter 2026 Results |
Globe Newswire |
04/17 |
16:01 |
| New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer |
Globe Newswire |
04/17 |
16:01 |
| Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting |
Globe Newswire |
04/17 |
16:01 |
| Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 |
Globe Newswire |
04/17 |
16:01 |
| Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities |
Globe Newswire |
04/17 |
16:00 |
